Archive for November 2018

Yesterday, the Food and Drug Administration (FDA) approved the drug Dsuvia (Sulfentanil – sublingual 30mcg tablet), a potent synthetic opioid, for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings such as hospitals, surgical centers and emergency departments. Intravenous Sulfentanil has been used…